BioSpace News Archive

Manufacturers in the cholesterol lowering drugs market are increasing research activities to include bempedoic acid for the development of new drugs.

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that it has become a vendor to Wawa, Inc. (“Wawa”), an American chain of convenience stores

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that management will participate in two upcoming virtual conferences. Conference Details: Jefferies Cell Therapy Virtual Summit Date/Time: Monday, October 5, 2020 at 11:30 a.m. EDT Format: Fireside chat 2020 Virtual Cell & Gene Meeting on the Mesa Date: Monday, October 12, 2020 – Friday, October

Rapid and accurate detection is essential to assess bacterial pneumonia co-infection in CO VID-19 critically ill patients Unyvero HPN panel demonstrated high negative predictive value (99.8% ) with potentially high clinical utility as rapid rule - out Unyvero reduces diagnostic turnaround times from days to less than 5 hours ; HPN panel viewed as a useful diagnostic tool to help with early detection and antimicrobial stewardship GAITHERSBURG, Md. and HOLZG

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that members of Navidea’s executive leadership team and Board of Directors will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Tuesday, September 29, 2020.

Why We Vaccinate, Inc., a 501 educational organization dedicated to provide a credible and trusted source for honest and factual information on vaccines, their efficacy, safety and importance to public health, announced the creation of its Scientific Advisory Board and the appointment of six new members.

Catabasis Pharmaceuticals Presents Information on Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystrophy, at the Virtual 25 th International Congress of the World Muscle Society -- New Preclinical Research Indicates that Edasalonexent Could Have Positive Effects on Cardiac Function and Preserve Bone Health --

Nimbus Therapeutics , a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the promotion of Abbas Kazimi to Chief Business Officer. Mr. Kazimi, who previously served as Vice President of Business Development, has more than 15 years of experience directing strategic transactions within the life sciences industry. “Throughout his tenure wit

CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company’’ or ''CLS’’, a diversified cannabis company operating as Cannabis Life Sciences, today announced its participation at the 2020 Virtual US Cannabis Symposium presented by Canaccord Genuity on September 30, 2020.

IQHQ, Inc., a premier life sciences real estate development company, today announced that it has completed the acquisition of an iconic development site along San Diego’s waterfront.